Ticker Details
LeMaitre Vascular, Inc. LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons.
IPO Date:	October 19, 2006
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$2.57B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.44 | 1.85%
Avg Daily Range (30 D):	$1.65 | 1.54%
Avg Daily Range (90 D):	$1.23 | 1.31%

Institutional Daily Volume
Avg Daily Volume:	.07M
Avg Daily Volume (30 D):	.21M
Avg Daily Volume (90 D):	.14M

Trade Size
Avg Trade Size (Sh.):	63
Avg Trade Size (Sh.) (30 D):	36
Avg Trade Size (Sh.) (90 D):	34

Institutional Trades
Total Institutional Trades:	1,723
Avg Institutional Trade:	$1.68M
Avg Institutional Trade (30 D):	$3.5M
Avg Institutional Trade (90 D):	$2.8M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.74M
Avg Closing Trade (30 D):	$4.94M
Avg Closing Trade (90 D):	$3.28M
Avg Closing Volume:	27.51K

News

Mar 28, 2026 @ 12:06 AM LeMaitre Vascular Up 30% as Insider Sells $285K in... Source: Jonathan Ponciano

Feb 27, 2026 @ 7:50 PM LeMaitre to Participate at Upcoming Investor Confe... Source: Na

Oct 9, 2025 @ 9:53 PM LeMaitre Will Announce Third Quarter 2025 Earnings... Source: Lemaitre Vascular, Inc.

Aug 6, 2025 @ 5:09 AM LeMaitre (LMAT) Q2 Revenue Jumps 15% Source: Jesterai

Jun 10, 2025 @ 2:52 AM Anteris Appoints David Roberts and Gregory Moss to... Source: Anteris Technologies Global Corp.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.55	$.69	$2.55
Diluted EPS	$2.52	$.68	$2.52
Revenue	$249.6M	$64.45M	$249.6M
Gross Profit	$178.54M	$46.19M	$178.54M
Net Income / Loss	$57.73M	$15.58M	$57.73M
Operating Income / Loss	$67.91M	$18.83M	$67.91M
Cost of Revenue	$71.06M	$18.26M	$71.06M
Net Cash Flow	$1.77M	$2.75M	$1.77M
PE Ratio	45.48